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Mapping of proteins involved in normal eye functions is a prerequisite to identify pathological changes during eye
disease processes. We therefore analysed the proteome of human vitreous by applying in-depth proteomic
screening technologies. For ethical reasons human vitreous samples were obtained by vitrectomy from “surrogate
normal patients” with epiretinal gliosis that is considered to constitute only negligible pathological vitreoretinal
changes. We applied different protein prefractionation strategies including liquid phase isoelectric focussing, 1D
SDS gel electrophoresis and a combination of both and compared the number of identified proteins obtained by
the respective method. Liquid phase isoelectric focussing followed by SDS gel electrophoresis increased the
number of identified proteins by a factor of five compared to the analysis of crude unseparated human vitreous.
Depending on the prefractionation method proteins were subjected to trypsin digestion either in-gel or in solution
and the resulting peptides were analysed on a UPLC system coupled online to an LTQ Orbitrap XL mass
spectrometer. The obtained mass spectra were searched against the SwissProt database using the Mascot search
engine. Bioinformatics tools were used to annotate known biological functions to the detected proteins. Following
this strategy we examined the vitreous proteomes of three individuals and identified 1111 unique proteins. Besides
structural, transport and binding proteins, we detected 261 proteins with known enzymatic activity, 51 proteases, 35
protease inhibitors, 35 members of complement and coagulation cascades, 15 peptide hormones, 5 growth factors,
11 cytokines, 47 receptors, 30 proteins of visual perception, 91 proteins involved in apoptosis regulation and 265
proteins with signalling activity. This highly complex mixture strikingly differs from the human plasma proteome.
Thus human vitreous fluid seems to be a unique body fluid. 262 unique proteins were detected which are present
in all three patient samples indicating that these might represent the constitutive protein pattern of human
vitreous. The presented catalogue of human vitreous proteins will enhance our understanding of physiological
processes in the eye and provides the groundwork for future studies on pathological vitreous proteome changes.
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The human vitreous humor is a clear aqueous solution
which fills the posterior compartment of the eye, located
between the lens and the retina. It occupies about 80%
of the volume of the eyeball and comprises 99% water
but has a gel-like structure at birth due to a network of
collagen fibrils and large molecules of hyaluronic acid.
With aging the vitreous undergoes a process of progres-
sive liquefaction so that at the age of 80–90 years more* Correspondence: juergen.kopitz@med.uni-heidelberg.de
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reproduction in any medium, provided the orthan half of the vitreous is liquid [1]. Vitreous humor
contains several low molecular weight solutes including
inorganic salts, sugars and ascorbic acid. The total con-
centration of protein in human vitreous is approximately
1200 μg/ml, of which collagen accounts for 180 μg/ml
[2]. Soluble proteins in vitreous humor are thought to
originate from plasma by filtration through fenestrated
capillaries of the ciliary body stroma via the iris root
[3,4]. However, protein secretion or shedding from pos-
terior chamber tissues, including photoreceptors and the
retinal pigment epithelium, may have a significant im-
pact on the pattern of soluble proteins found in the vit-
reous. Since, as in all other human tissues, a majortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of homeostasis in adjacent tissues, vitreous fluid con-
tains soluble proteins that are necessary to sustain nor-
mal ocular morphology and functions. Such important
physiological role requires tight control of the qualitative
and quantitative composition of the vitreous proteome.
Consequently the vitreous in the healthy eye should contain
a complex but defined protein mixture. Studies investigat-
ing the vitreous proteome provide valuable information for
the understanding of ocular biochemistry. Conversely, if the
protein composition of the vitreous is central to the health
of the human eye, alterations in vitreous protein expression
will be on one hand indicative of ocular disease, on the
other hand may be actively involved in the pathogenic
process. Indeed, a number of vitreous fluid proteins have
already been linked to the aetiology of ocular and
vitreoretinal disorders [5,6]. However, we are still far from a
detailed understanding of the complex biochemical pro-
cesses mediated by vitreous proteins, and consequently ex-
tensive analysis of the role of vitreous proteome changes in
the development of eye diseases is not yet feasible.
Towards a better understanding of vitreous protein
composition and functions a number of proteomic ana-
lyses have already been conducted. In recent studies only
38 resp. 121 individual proteins were identified in
human vitreous humor [7,8]. By applying different prote-
omic methods including 2-DE/MALDI-MS, nanoLC-
MALDI-MS/MS, and nanoLC-ESI-MS/MS a total of 346
individual proteins were identified in vitreous of a non-
diabetic control group [9]. In a recent study 355 proteins
were identified by nano-LC-ESI-MS/MS and 206 pro-
teins by antibody-based protein arrays in human aque-
ous humor whose composition may be similar to the
vitreous body [10]. Analysis of aqueous humor collected
during routine cataract surgery from otherwise healthy
eyes identified 198 unique proteins [11]. However, con-
sidering the complexity of other body fluids like blood
plasma or cerebrospinal fluid containing thousands of
different proteins, it is likely to assume that only the
most abundant proteins in the vitreous have been
detected up to now. Indeed in the present study applying
state-of-the art proteomics technologies we were able to




Following approval by the ethics review board of the
University Hospital Bonn, vitreous material was sampled
from patients undergoing elective pars plana vitrectomy
for epiretinal gliosis at the Bonn University Eye Hospital.
Written consent from the patients was obtained for use
of the samples in the present study. Patients with previ-
ous vitreoretinal surgery, intravitreal drug injections, oradditional vitreoretinal diseases were excluded. During
vitrectomy, complete vitreous material diluted in surgi-
cal irrigation fluid (balanced salt solution; PuriSol, Carl
Zeiss Meditec, Jena, Germany) was collected. Samples
were stored frozen at −80°C immediately after surgery
until analysis. Contamination with blood during surgery
was excluded by haemoglobin ELISA (Bethyl Laborator-
ies; Montgomery, TX, USA). Only samples without de-
tectable haemoglobin were used in this study. The test
has a detection limit of 0.27 ng/ml.
Sample processing and fractionation
Before further processing, protein content of the vitre-
ous samples was determined by the Lowry procedure
[12]. Protein was precipitated from aliquots of vitreous
samples (representing 50 μg of protein for SDS poly-
acrylamide gel electrophoresis (SDS PAGE) and 1mg for
liquid phase isoelectric focussing (liquid phase IEF)) by
adding an equal volume of 10% trichloroacetic acid
(TCA). After centrifugation (15 min, 15000 g, 4°C) and
washing with 1ml ice-cold acetone the protein pellet
was dried for ~10 min in vacuo and resolubilized for
SDS PAGE or liquid phase IEF.
For SDS-PAGE vitreous protein precipitate was
dissolved in NuPAGE LDS sample buffer and separated
on a NuPAGE Novex 4-12% Bis Tris gel (Invitrogen,
Carlsbad, CA, USA) following the manufacturer’s in-
structions. The gel was Coomassie-stained according to
the procedure of Kang et al. [13] and each lane was cut
into 26 pieces. Liquid phase IEF was conducted in a
ZOOM® IEF Fractionator (Invitrogen). To this end the
protein precipitate (1 mg) was dissolved in 900 μl 1.1×
IEF Denaturant (7.7 M urea, 2.2 M thiourea, 4.4%
CHAPS). Then 10 μl 100× protease inhibitor (90 mM
AEBSF, 430 mM EDTA, 8.5 mM Bestatin, 1.4 mM
Pepstatin A, 1.1 mM E-64, 1.0 mM Leupeptin) and 10 μl
2 M DTT were added. The mixture was sonicated (10
rounds / 10 s / 50% power), and 10 μl 1 M Tris base
were added, followed by an incubation time of 30 min at
room temperature (RT). 5.2 μl of dimethylacetamide
were added and incubated for further 30 min at RT. Fi-
nally 10 μl of ZOOM carrier ampholytes (pH3-10) and
10 μl 2 M DTT were added to the sample solution. The
whole mixture was filled up to a final volume of 3.5 ml
with IEF denaturant and loaded to the ZOOM IEF
fractionator. A trace of bromophenol blue visualized
direction of the sample movement. Settings for separ-
ation were: current 2 mA, power 2W, voltage 100V for
20 min / 200V for 80 min / 600V for 80 min. Separation
yielded 5 fractions of about 650 μl representing pH ran-
ges of 3,0 - 4,6 (fraction 1), 4,6 - 5,4 (fraction 2), 5,4 –
6,2 (fraction 3), 6,2 – 7,0 (fraction 4), 7,0 – 10 (fraction
5). To obtain similar amounts of protein for further sep-
aration by SDS PAGE protein was precipitated from
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3, 90 μl of fraction 4 and 300 μl of fraction 5 by TCA/
acetone as described above.
Preparation of samples for protein identification
In-solution digestion
Proteins in the individual IEF fractions were reduced,
alkylated and digested in solution with trypsin. Briefly,
after TCA precipitation, the dried pellet was re-
suspended in 20 μl 40 mM NH4HCO3. 2 μl DTT
(10 mM DTT in NH4HCO3) was added to the solution
and proteins were reduced at 45°C for 1 h. Free cys-
teine residues were alkylated with 1 μl iodoacetamide
(55 mM in 40 mM NH4HCO3) for 30 min at 25°C in
the dark, followed by the addition of 2.5 μl DTT. The
mixture was incubated at 37°C for 15 min in a
thermomixer (600 rpm). Afterwards, trypsin (1/100
w/w of precipitated protein amount) was added and
proteins were digested at 37°C overnight.
In-gel digestion
Proteins in the individual gel slices were reduced,
alkylated and in-gel digested with trypsin [14]. Brief-
ly, after incubation with 150 μl water at 37°C for 5 min,
water was removed (washing step) and gel pieces were
shrunk by dehydration with 150 μl water/acetonitrile
50:50 (v/v) at 37°C for 5 min in a thermo mixer (600
rpm). The solution was removed and the proteins were
reduced with 100 μl 10 mM DTT in 40 mM NH4HCO3
for 1 h at 56°C. The solution was removed and gel pieces
were incubated with 150 μl water for 5 min at 37°C.
After removing the solution from the gel plugs proteins
were alkylated with 100 μl 55 mM iodoacetamide in 40
mM NH4HCO3 for 30 min at 25°C in the dark, followed
by three alternating washing steps each with 150 μl of
water and water/acetonitrile 50:50 (v/v) for 8 min at
37°C. Gel pieces were then dehydrated with 100 μl
acetonitrile for 1 min at RT, dried for 15 min and subse-
quently rehydrated with porcine trypsin (sequencing
grade, Promega, Mannheim, Germany) with a minimal
volume sufficient to cover the gel pieces after rehydra-
tion (100 ng trypsin in 40 mM NH4HCO3). Samples
were incubated overnight at 37°C.
Extraction
After overnight digestion the supernatant was collected
in PCR tubes while gel pieces were subjected to four fur-
ther extraction steps. Gel pieces were sonicated for 5
min in acetonitrile/0.1% aqueous TFA 50:50 (v/v). Fol-
lowing centrifugation the supernatant was collected and
gel pieces were sonicated for 5 min in acetonitrile. After
collecting the supernatant gel pieces were sonicated for
5 min in 0.1% TFA followed by another extraction step
with acetonitrile. The combined solutions were dried ina speed-vac at 37°C for 2 h. Peptides were redissolved in
5 μl 0.1% TFA by sonication for 5 min and subsequently
analysed by nanoLC ESI-MS/MS.ESI-MS/MS analysis and database search
Tryptic peptide mixtures were separated using a na-
noAcquity UPLC system. A C18 trap column (180 μm ×
20 mm) with a particle size of 5 μm was used (Waters
GmbH, Eschborn, Germany). Liquid chromatography sep-
aration was performed on a BEH130 C18 main-column
(100 μm × 100 mm) with a particle size of 1.7 μm (Waters
GmbH, Eschborn, Germany) at a flow rate of 0.4 μl / min.
Gel slices 1–7, 12–17 and 22–26 were separated by a 1 h
gradient whereas slices 8–11 and 18–21 were fractionated
by a 2 h gradient. The 1 h gradient was set as follows: from
0 to 4% B in 1 min, from 4 to 40% B in 39 min, from 40 to
60% B in 5 min, from 60 to 85% B in 0.1 min, 6 min at
85% B, from 85 to 0% B in 0.1 min, and 9 min at 0% B.
The 2 h gradient started from 0 to 4% B in 1 min, from 4%
to 30% in 79 min. The next step was set from 30 to 45% B
within 10min followed by an increase in 10 min of solvent
B from 45 to 90% and for a further 10 min at 90% solvent
B. After this step the concentration was stepped down to
0% solvent B and continued for 15 min. Solvent A
contained 98.9% water, 1% acetonitrile and 0.1% formic
acid, solvent B contained 99.9% acetonitrile and 0.1% for-
mic acid. The nanoUPLC system was coupled online to an
LTQ Orbitrap XL mass spectrometer (Thermo Scientific,
Bremen, Germany).Data were acquired by scan cycles of
one FTMS scan with a resolution of 60000 at m/z 400 and
a range from 300 to 2000 m/z in parallel with six MS/MS
scans in the ion trap of the most abundant precursor ions.
The mgf-files were used for database searches with the
MASCOT search engine (Matrix Science, London, UK;
version 2.2) against SwissProt database (http://www.
expasy.ch/sprot/sprot-top.html Rel. 2011_05). Taxonomy
was set to human. The peptide mass tolerance for data-
base searches was 10 ppm and fragment mass tolerance
0.4 Da. Carbamidomethylation of C was set as fixed
modification. Variable modifications included oxidation
of M and deamidation of N and Q. One missed cleavage
site in case of incomplete trypsin hydrolysis was allowed.
Ion score cut off was set to 20. Proteins were considered
as identified if two unique peptides were detected and at
least one peptide had an individual ion score exceeding
the MASCOT identity threshold of 26. Identification
under the applied search parameters refers to False Dis-
covery Rate (FDR) < 3,5% and a match probability of
p<0.05, where p is the probability that the observed
match is a random event. We indicated proteins for
which only one peptide matched the threshold of 26 by
an asterisk in all tables provided in the results section as
well as in the supplementary material. Each gel slice was
Figure 1 Experimental work flow for vitreous humor proteome analysis. The grey coloured boxes depict the work flow of the standard
procedure for proteomic analysis of vitreous humor. After precipitation vitreous proteins were separated by 1D SDS gel electrophoresis. Following
Coomassie staining lanes were cut into 26 slices of the same size. Proteins in each individual slice were subjected to in-gel digestion with trypsin. MS/MS
data obtained by nanoLC-ESI-MS/MS analysis were searched with the MASCOT search engine against SwissProt database. In order to test alternative
experimental strategies different variants of the standard procedure were applied. Variant 1: Liquid phase IEF was used as additional prefractionation step
before SDS-gel electrophoresis. Variant 2: Samples obtained from liquid phase IEF were directly applied for nanoLC-ESI-MS/MS analysis. Variant 3: Vitreous
proteins obtained after TCA/acetone precipitation was directly subjected to nanoLC-ESI-MS/MS analysis without any prefractionation.
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to protein database search.
Data analysis
Web-based tools for classification and functional anno-
tation of all proteins by their GO number were used.
First, we used DAVID Bioinformatics Resources (the
Database for Annotation, Visualization and Integration
Discovery [15,16]. The SwissProt ID list was pasted and
Uniprot IDentifier was chosen to establish a gene list.
The function “Functional annotation table” using GO
terms (Cellular Component, Molecular Function, Bio-
logical Process, Protein Class) were chosen. Second,
the classification System PANTHER (Protein ANalysis
THrough Evolutionary Relationships) [17,18], Batch ID
upload, was used creating a similar annotation table with
the GO terms (CC, MF, BP,PC). Search procedure was
again performed by using SwissProt identification
numbers.The GO terms which were in common in both
tables were used for annotation of the proteins.
“Secreted proteins” were annotated according to
DAVID’s SP-PIR-Keywords.
Proteins which were still unknown and could not be
analyzed were run through the DomainSweep pipeline
which identifies the domain architecture within a protein
sequence [19]. Domain hits are listed as ‘significant’ by
DomainSweep
i. if two or more hits belong to the same INTERPRO
family. The task compares all true positive hits of the
different protein family databases grouping together
those hits, which are members of the same INTERPRO
family/domain.
ii. if the motif shows the same order as described in
PRINTS or BLOCKS. Both databases characterize a pro-
tein family with a group of highly conserved motifs/seg-
ments in a well-defined order. The task compares the
Figure 2 SDS gel electrophoresis of vitreous protein samples.
Vitreous protein samples obtained from three individuals were
separated on a NuPAGETM 4–12% Bis-Tris mini gel using MES
running buffer, Coomassie stained, cut into 26 slices and analyzed
according to the standard procedure depicted in Figure 1.
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described in the corresponding PRINTS or BLOCKS
entry. Only hits in correct order are accepted.
All other hits above the trusted thresholds are listed as
‘putative’. They are significant within the domain data-
base searched.
Results
Complete vitreous material of three individuals (2 males,
1 female; age range 68–83 years) was collected. The
three individuals were not related to each other. All were
phakic at the time of operation. None was suffering from
diabetes, dyslipidemia, or obesity (defined as BMI>30).
Individual 1 and 2 received medical treatment for
hypertension, individuals 2 and 3 for hypothyroidism. In
addition, individual 1 was suffering from coronary heart
disease, and individual 3 from benign prostate hyperplasia.
No significant other medical conditions were present. The
proteome of each individual vitreous sample (VP1, VP2,
VP3) was analyzed according to the work flow (standard
procedure) outlined in Figure 1. The result of protein
prefractionation by SDS gel electrophoresis (standard pro-
cedure) is shown in Figure 2. 463 unique proteins were
detected in VP1, 434 in VP2, and 372 in VP3. All detected
proteins are listed in Additional file 1: Table S1 togetherwith their accession number, molecular weight, isoelectric
point (pI), Mascot score, number of unique peptides and
sequence coverage. 242 of these proteins were found in all
of the three samples, 137 in two samples, whereas 265 pro-
teins were detected in only one of the three samples. In
order to test whether additional prefractionation of the
samples by liquid phase isolelectric focussing prior to SDS
gel electrophoresis (variant 1 in Figure 1) may enable
digging deeper into the vitreous proteome, sample VP2 was
subjected to such prefractionation procedure which reduces
sample complexity by resolving the proteome into 5
fractions according to the proteins’ isoelectric points. The
total number of identified proteins in vitreous sample VP2
increased to 916 by liquid IEF combined with SDS PAGE,
but 66 proteins detectable by the standard procedure were
lost by applying such additional prefractionation (Figure 3).
On the other hand, when liquid phase IEF was applied
without subsequent SDS-gel electrophoresis (variant 2 in
Figure 1) only 284 proteins were detectable in VP2,
however among these were 17 additional proteins not
detected in the standard procedure. Likewise direct analysis
of the vitreous proteome without any prefraction (variant 3
in Figure 1) revealed only 186 proteins, but 2 new proteins
(ABHEB and NPC2) were detected. A comparison of the
different prefractionation methods is shown in Figure 4.
Adding the proteins that were obviously lost during
prefractionation and the low abundance proteins
which became only detectable after liquid phase IEF
prefractionation, the list of vitreous proteins grew
to 1111 distinct protein species (Additional file 1:
Table S1). Among the proteins detectable by pre-
fractionation variant 1, 20 proteins emerged in VP2
that were also found in VP1 and VP3 by the standard
procedure. Thus these proteins were added to compil-
ation of proteins detectable in all samples yielding a
total number of 262 unique proteins detectable in all
individuals (Additional file 2: Table S2).
Annotation of protein functions was achieved by the
DAVID Bioinformatics tool using the SwissProt entries.
1105 proteins were found classified in the database, 6
are designated as uncharacterized. The result is outlined
in Figure 5. Details are given in Additional file 3: Table S3.
A total number of 210 proteins where annotated as se-
creted proteins. In order to detect specific differences
between the plasma and the vitreous proteome our
results were compared to a comprehensive catalogue
of the plasma proteome (www.hupo.org), where 3020
plasma proteins were identified based on two or more
peptides. Figure 6 summarizes the comparison between
this map of the human plasma proteome and the
vitreous proteins detected in our study. 764 proteins of
the complete list of 1111 individual proteins are not
listed in the HUPO plasma proteome catalogue. In
Additional file 2: Table S2 and Additional file 3: Table S3
Figure 3 Combined liquid phase IEF and SDS gel electrophoresis prefractionation (Variant 1). a: Vitreous protein sample VP2 was
prefractionated by liquid phase IEF in a Zoom FractionatorTM (Invitrogen) yielding 5 fractions representing the indicated IP ranges. Each individual
fraction was separated by SDS gel electrophoresis as described in the legend to Figure 2. The complete work flow is outlined as variant 1 in
Figure 1. b: Overview of the total number of identified proteins in the different pH fractions obtained by variant 1. Details on the proteins are
given in Additional file 1: Table S1.
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Figure 4 Comparison of different prefractionation strategies.
Vitreous protein sample VP2 was analyzed with four different
prefractionation strategies according to the work flow outlined in
Figure 1. The bars represent the total number of proteins detected
by each individual method. The black part of the bars represents
proteins detectable with the standard procedure. The grey part
indicates proteins that were detected with the variant method but
were not found applying the standard procedure.
Figure 5 Annotation of protein function. Functional annotation of each
Materials and Methods. Details are given in Additional file 3: Table S3.
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are indicated.Discussion
Ethical feasibility largely confines vitreous material sam-
pling for research purposes to individuals that receive
vitreous removal surgery (vitrectomy) for medical rea-
sons, i.e. as a treatment for vitreoretinal diseases such as
diabetic retinopathy. As vitrectomies are not performed
in healthy persons, most previous studies on the vitre-
ous proteome employed control groups of “surrogate
normal patients” with diseases such as epiretinal
gliosis, vitreomacular traction syndrome, and idio-
pathic macular hole that are considered to constitute
only comparatively minor pathological vitreoretinal
changes [9,20,21]. In our study, we examined vitreous
material from three patients with epiretinal gliosis
(also: epiretinal membrane, macular pucker), a disease
in which retinal cells form a thin membrane on the
inner retinal surface that causes visual distortions and
decline [22]. Our study thus presents a catalogue of the
vitreous proteome in the absence of neurodegenera-
tive, ischemic, and vasoproliferative retinal changes
associated with many other retinal diseases and pro-
vides a baseline for future comparative proteomic





























Figure 6 Comparison of vitreous proteome with plasma
proteome. The list of vitreous proteins obtained in our study is
compared to a map of plasma proteins from the human proteome
project. The black part of the bar representing the vitreous
proteome indicates proteins that are also found in the plasma
proteome map. The grey part indicates proteins not listed for the
plasma proteome.
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ition of the human vitreous humor is much more com-
plex than might be expected from previous proteome
analyses. A very similar protein pattern can be expected
for aqueous humor filling the anterior eye chamber be-
tween the cornea and lens, since the gel-like vitreous
humor consists of 99% fluid and there is a continuous
exchange between the aqueous humor and the vitreous
humor located in the posterior part of the eye behind
the lens. Such exchange is also reflected by the detection
of the lens-specific crystallins in the vitreous humor. 262
unique proteins were detected which are present in all
three patient samples indicating that these might repre-
sent the constitutive protein pattern of human vitreous.
However, there also seems to exist a striking heterogen-
eity between the individual samples, as 236 proteins
were only detectable in one sample and 196 proteins
were found in two of the three specimen. Such hetero-
geneity may be a common feature of human biological
fluids as exemplified by human plasma which also shows
broad interindividual differences, in particular with re-
gard to lower abundance proteins [23]. This should be
kept in mind when the vitreous proteome of patients
with eye disorders is screened for specific disease
markers. In particular, some of the proteins that were
not identified in at least two of the three subjects may
not represent “normal” vitreous proteins. In general it is
difficult to distinguish between the proteins that are ac-
tively secreted to the human vitreous and proteins intro-
duced by low-level tissue leakage. The annotation as
secreted protein given in Additional file 2: Table S2 and
Additional file 3: Table S3 may serve as a rough guide-
line. Various keratins were detected in the samples.
However, in particular the keratins 1, 2, 5, 9, 10 and 14
are known contaminants that may occur during sample
preparation [24]. Since collection of the clinical samples
in a keratin free environment was not feasible, these
keratins might have arrived in the samples through
contamination rather than through natural abundance in
vitreous humor.
Although we applied a highly sensitive state-of-the-
art methodology to map the vitreous proteome, only
further prefractionation of the samples enabled detec-
tion of very low abundance proteins. Thus applying
liquid phase isolelectric focussing as prefractionation
strategy in combination with 1D SDS PAGE facilitated
a striking increase in the dynamic range of detection,
i.e. the number of proteins detected in sample VP2
increased from 434 for the gel separated sample to 916.
Consequently liquid phase IEF might also be applied
for efficient prefractionation prior to detection by
other methods, including Western blotting or ELISA
techniques, in studies on very low abundance proteins.
On the other hand our results clearly indicate that
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esis or liquid phase IEF some proteins will be lost.
Thus a combination of different prefractionation
strategies is necessary to cover the complete vitreous
proteome.
Comparison of the map of vitreous proteins obtained in
our study with the HUPO plasma proteome indicates that
the vitreous proteome strikingly differs from the plasma
proteome. Thus considering the complete list of all 1111
proteins detected in the vitreous samples, only about 27%
are listed also as plasma proteins. Relating to the 262 “con-
stitutive” vitreous proteins only about 50% are known
plasma proteins. Consequently the aqueous phase of hu-
man vitreous appears to be a discrete and unique body fluid
with only partial overlap to other extracellular fluid body
compartments. This is contradictory to the assumption that
most protein species of the vitreous originate from plasma.
The detection of crystallins may indicate that protein re-
lease from the lens could also contribute to the vitreous
proteome. However, recent studies indicate that crystallins
are also synthesized in the retina. Crystallins may have
several metabolic and regulatory functions. Their synthesis
is dramatically up regulated by a large range of diseases,
including diabetic retinopathy, age-related macular
degeneration, uveitis, trauma and ischemia. Further
investigations on the origin as well as on normal and
pathological functions of crystallins in the vitreous may
help to understand the aetiology of the above mentioned
disorders [25]. The detection of dermcidin, an antimicro-
bial peptide commonly considered to be a primitive
mechanism of immunity, in human vitreous is another in-
teresting finding [26]. Recently this peptide was also iden-
tified in tear fluid [27]. Galectin-1 is an example of a
protein with potential adhesion/growth regulatory func-
tions in the eye [28], but has not been annotated as a
plasma protein. Lengsin is an eye lens-specific member of
the glutamine synthetase superfamily [29]. Opticin is a
classical vitreous protein, where it is associated with
humor collagen fibrils [30]. Some of the detected proteins
such as retinoschisin and retbindin are specifically se-
creted by photoreceptor cells [31,32] which indicates that
cells of all retinal layers including the outer retina contrib-
ute proteins to the vitreous proteome. A previous analysis
of the secretome of cultured human RPE indicates that
RPE cells secrete a variety of proteins (73 individual
proteins) including extracellular matrix proteins, cell
adhesion proteins, complement factors, proteases, prote-
ase inhibitors, enzymes and growth factors, that may be
involved in normal functions of the eye as well as in the
pathogenesis of eye disorders [33]. Therefore a compre-
hensive in-depth analysis of the RPE secretome and com-
parison to the vitreous proteome will help to assess the
contribution of the RPE to the vitreous proteome compos-
ition and function.Conclusions
Human vitreous appears to be a discrete and unique body
fluid with only partial overlap to the plasma proteome. Our
findings suggest that vitreous proteome analysis may prove
useful in examining all retinal diseases, even those primarily
affecting the outer retina such as age-related macular
degeneration and most hereditary retinal dystrophies.
Altogether this study provides the most comprehensive hu-
man vitreous proteome coverage and list reported to date.
The protein set has immediate utility for investigators
interested in using vitreous samples to study eye disorders,
including widespread diseases like age-related macular
degeneration or diabetic retinopathies.
In addition a comparison of different prefractionation
methods for comprehensive proteome analysis of a largely
uncharacterized human body fluid is given with the ex-
ample of human vitreous, indicating that human vitreous
contains a variety of low abundance proteins that were only
detectable by employing efficient prefractionation methods
like liquid phase isoelectric focussing.
Additional files
Additional file 1: Table 1. Proteins found in any of the three samples.
All vitreous humor proteins detected in our study are compiled in
alphabetical order. A protein was considered as identified if two peptides
were detected with ion score cut off set to 20 and at least one peptide
had an individual ion score exceeding the MASCOT identity threshold
above 26. Mascot scores for all identified proteins in relation to the
sample and analytic procedure are given. If no score is given the protein
was not detected in this patient sample or by this work-up procedure.
Additional file 2: Table S2. Proteins found in vitreous protein samples
from all three patients.
Additional file 3: Table S3. Functional annotation of vitreous proteins.
Classification and functional annotation was conducted as described in
Materials and Methods. P: proteins catalogued or annotated as plasma
proteins; S: predicted as secreted proteins. The Roman numerals indicate
the following annotations; I: Enzymes, II: Proteases, III: Protease Inhibitors,
IV: Complement and coagulation system, V: Growths factors, VI: Cytokines,
VII: Peptide hormones, VIII: Transport, IX: Receptors, X: Structure, XI: Visual
perception, XII: Ion channel activity, XIII: Binding, XIV: Apoptosis, XV:
Cytoskeleton, XVI: Signaling, XVII: Intercellular, XVIII: Miscellaneous
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